A multicenter phase Ib clinical trial of myelin oligodendrocyte glycoprotein transduced T cells in patients with insulin-dependent type 1-diabetes
Latest Information Update: 23 Aug 2017
At a glance
- Drugs MOG transduced T cells ImCyse (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 23 Aug 2017 New trial record